Good doctor Pharmaceutical Group and hospital "marriage" to build preparation center

[pharmaceutical network industry trends] recently, gooddoctor Pharmaceutical Group and the Municipal Hospital of traditional Chinese medicine held a signing ceremony for jointly building a pharmaceutical center The two sides will strengthen cooperation in pharmaceutical operation and management, collection of empirical prescriptions, product research and development, market development, etc., to achieve mutual benefit and win-win results, so as to serve patients with higher quality and the masses It is reported that the city's traditional Chinese medicine hospital has 71 batches and 11 dosage forms awarded by the provincial market supervision administration According to the agreement of co construction, the Municipal Hospital of traditional Chinese medicine will move the existing preparation room as a whole, put the existing preparation equipment, approval documents, technology and personnel into the preparation center and carry out self production and quality control At the same time, gooddoctor Pharmaceutical Group is responsible for providing the site, leading the new construction, acceptance and insufficient equipment procurement of the preparation center, providing the preparation center with distribution services of Chinese herbal pieces that meet the national standards, and comprehensively reforming and upgrading the production scale, environment and standardization The signing ceremony also put forward three requirements for the work of the new preparation center First, the construction of buildings, environment, equipment, facilities and other aspects should be carried out at a high starting point and promoted at a high standard; second, the preparation production should be carried out in strict accordance with the preparation standards and specifications to ensure the quality of the brand; third, both sides should establish an open and win-win concept, deepen practical cooperation in scientific research, preparation research and development, cream production, product promotion, talent training and other aspects to ensure effectiveness The industry said that with the deepening of the reshuffle of the pharmaceutical industry, multilateral cooperation of pharmaceutical enterprises has become a business model exploration and evolution under the reallocation and integration of resources   At present, in addition to good doctor pharmaceutical enterprises, Shanghai Pharmaceutical Co., Ltd has been adhering to the concept of cooperative development for many years, and has successively cooperated with many universities, hospitals and scientific research institutes, effectively enhancing the company's scientific and technological innovation vitality; Xi'an labor union hospital and Panlong Pharmaceutical Co., Ltd signed a signing ceremony for the letter of intent for strategic cooperation; Dongcheng Pharmaceutical Co., Ltd signed a strategic cooperation agreement with Beijing Tumor Hospital, and both parties signed a strategic cooperation agreement We will build a clinical transformation base for nuclear drugs in the field of cancer, and speed up the acquisition of listing documents for new nuclear drug products In addition to cooperation with hospitals, many pharmaceutical companies have also made acquisitions of hospitals in the past It is worth mentioning that under a series of new policies of medical reform, such as consistency evaluation, two vote system, and 4 + 7 volume procurement, due to the long return period and large investment of the hospital, the enthusiasm of pharmaceutical companies for purchasing hospitals in the past has gradually cooled down, and even many pharmaceutical companies are "selling" hospitals The author has learned that in recent years, drug companies are selling hospitals more and more frequently For example, on December 25, 2018, Jingfeng pharmaceutical announced to sell 100% equity of Chengdu Jinsha hospital to Deyang fifth hospital Co., Ltd at a price of 150 million yuan; on December 19, 2018, Yibai pharmaceutical also announced to transfer its 53% equity of Huainan Chaoyang Hospital Management Co., Ltd to Huainan and Hui Enterprise Management Co., Ltd at a price of 660 million yuan According to the data, although the number of hospitals acquired by Chinese hospitals in 2018 is the same as that in 2016, the transaction amount is only half of that in 2016, and the proportion of public hospitals in the acquisition has decreased from 62% in 2016 to less than 19% According to the analysis of the industry, many pharmaceutical companies purchase hospitals for the purpose of transformation or increasing business units, and the strategy itself is indisputable, but the medical field has its own characteristics, such as long investment return cycle, heavy assets, strong regional characteristics of the hospital, etc., which make it difficult for the investors to obtain rich returns in a short period of time, and to meet the investment expectations of the investors Therefore, pharmaceutical companies need to consider the purchase of hospitals comprehensively, and do not make impulsive decisions.